Diversified Trust CO Moderna, Inc. Transaction History

Diversified Trust CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 08, 2024	BUY	$69.51 - $104.43 $311,891 - $468,577	4,487 New	4,487 $446,000
Q1 2023 Apr 07, 2023	SELL	$135.66 - $197.02 $13,972 - $20,293	-103 Reduced 4.21%	2,343 $359,000
Q4 2022 Jan 17, 2023	SELL	$118.38 - $210.04 $51,968 - $92,207	-439 Reduced 15.22%	2,446 $439,000
Q3 2022 Oct 14, 2022	BUY	$118.07 - $194.18 $18,064 - $29,709	153 Added 5.6%	2,885 $341,000
Q2 2022 Jul 12, 2022	SELL	$117.13 - $176.59 $18,389 - $27,724	-157 Reduced 5.43%	2,732 $390,000
Q1 2022 Apr 07, 2022	BUY	$126.46 - $235.05 $17,325 - $32,201	137 Added 4.98%	2,889 $498,000
Q4 2021 Jan 13, 2022	SELL	$225.82 - $368.51 $3,613 - $5,896	-16 Reduced 0.58%	2,752 $699,000
Q3 2021 Jan 13, 2022	BUY	$221.9 - $484.47 $86,762 - $189,427	391 Added 16.45%	2,768 $1.07 Million
Q2 2021 Jul 20, 2021	SELL	$129.91 - $234.98 $6,625 - $11,983	-51 Reduced 2.1%	2,377 $559,000
Q1 2021 May 10, 2021	BUY	$109.18 - $185.98 $49,786 - $84,806	456 Added 23.12%	2,428 $318,000
Q4 2020 Jan 08, 2021	BUY	$65.74 - $169.86 $129,639 - $334,963	1,972 New	1,972 $206,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.